EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Multi-Omics Analysis Unveils Distinct Molecular Subtypes and a Robust Immune–Metabolic Prognostic Model in Clear Cell Renal Cell Carcinoma

Yilin Zhu, Shihui Yu, Dan Yang, Tian Yu, Yi Liu, Wenlong Du iD

International Journal of Molecular Sciences · 28.03.2025 · 26 (7) · 3125

DOI: 10.3390/ijms26073125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2025. Verfasst von Yilin Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Excellent Talents Research Foundation of Xuzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is characterized by significant clinical and molecular heterogeneity, with immune and metabolic processes playing crucial roles in tumor progression and influencing patient outcomes. This study aims to elucidate the molecular subtypes of ccRCC by employing non-negative matrix factorization (NMF) clustering on differentially expressed genes (DEGs), thereby identifying distinct transcriptional profiles, immune cell infiltration patterns, and subsequent survival outcomes. Utilizing NMF clustering, we identified two molecular subtypes of ccRCC. We developed a prognostic model using LASSO–Cox regression, validated with multiple datasets and quantitative reverse transcription polymerase chain reaction (qRT-PCR), incorporating ten immunity- and metabolism-related genes (IMRGs) for overall survival (OS) prediction. Immune cell infiltration and tumor mutational burden (TMB) analyses were performed to explore differences between high- and low-risk groups, while Gene Set Enrichment Analysis (GSEA) provided insights into relevant biological pathways. The findings revealed that subtype C1, characterized by a “cold” tumor microenvironment, correlates with better prognostic outcomes compared to subtype C2, which exhibits an immunologically active environment and worse survival prospects. High-risk patients demonstrated poorer OS associated with alterations in immune and metabolic pathways. Immune checkpoint analysis indicated the upregulation of CTLA4, LAG3, and LGALS9 in high-risk patients, suggesting potential therapeutic targets. A nomogram integrating IMRG risk scores with clinical factors displayed high predictive accuracy for 1-, 3-, and 5-year OS. These findings provide novel insights into the molecular heterogeneity of ccRCC and emphasize the interconnected roles of immune dysregulation and metabolic alterations in tumor progression. By identifying key prognostic biomarkers and potential therapeutic targets, this study paves the way for innovative strategies aimed at harnessing immune and metabolic pathways for better clinical outcomes in ccRCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansPrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticTumor MicroenvironmentGene Expression ProfilingTranscriptomeMaleFemaleMultiomics

Stichwörter der Autor:innen

clear cell renal cell carcinomaimmunotherapymolecular subtypesprognostic signaturetumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China.
  • Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.

ORCID-Profile: Wenlong Du

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Excellent Talents Research Foundation of Xuzhou Medical University

Zitieren

APA

Zhu, Y., Yu, S., Yang, D., Yu, T., Liu, Y., & Du, W. (2025). Integrated Multi-Omics Analysis Unveils Distinct Molecular Subtypes and a Robust Immune–Metabolic Prognostic Model in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences, 26(7), 3125. https://doi.org/10.3390/ijms26073125

Vancouver

Zhu Y, Yu S, Yang D, Yu T, Liu Y, Du W. Integrated Multi-Omics Analysis Unveils Distinct Molecular Subtypes and a Robust Immune–Metabolic Prognostic Model in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 2025;26(7):3125. doi:10.3390/ijms26073125

BibTeX
@article{Zhu2025,
  author = {Zhu, Yilin and Yu, Shihui and Yang, Dan and Yu, Tian and Liu, Yi and Du, Wenlong},
  title = {Integrated Multi-Omics Analysis Unveils Distinct Molecular Subtypes and a Robust Immune–Metabolic Prognostic Model in Clear Cell Renal Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {7},
  pages = {3125},
  doi = {10.3390/ijms26073125}
}
Kostenlos starten →